BioTuesdays

Category - Markets

Rocket Pharmaceuticals Logo
Markets

WB starts Rocket Pharma at OP; FVE $32

William Blair launched coverage of Rocket Pharmaceuticals (NASDAQ:RCKT) with an “outperform” rating and fair value estimate of $32. The stock finished at $19.17 on July 9. Rocket is focused on developing first-in-class...

July 10, 2018
ContraFect Logo
Markets

Ladenburg starts ContraFect at buy; PT $3

Ladenburg Thalmann initiated coverage of ContraFect (NASDAQ:CFRX) with a “buy” rating and $3 price target. The stock closed at $2.59 on July 9. “We view ContraFect as a biologics story with a potential first-in-class...

July 10, 2018
KalVista Pharmaceuticals Logo
Markets

Roth starts Kalvista Pharma at buy; PT $20

Roth Capital Partners launched coverage of Kalvista Pharmaceuticals (NASDAQ:KALV) with a “buy” rating and price target of $20. The stock closed at $8.82 on July 9. Analyst Jotin Marango writes that behind its cultivated...

July 10, 2018
RXi Logo
Markets

HCW starts RXi Pharma at buy; PT $3

H.C. Wainwright launched coverage of RXi Pharmaceuticals (NASDAQ:RXII) with a “buy” rating and price target of $3. The stock closed at $1.97 on July 6. RXi is focused on improving the efficiency and anti-tumor activity...

July 9, 2018
Epizyme Logo
Markets

Leerink cuts Epizyme to market perform and PT to $16

Leerink downgraded Epizyme (NASDAQ:EPZM) to “market perform” from “outperform” and lowered its price target to $16 from $24 after making extensive changes to its revenue forecasts for Epizyme’s only drug, tazemetostat...

July 3, 2018
Celyad Logo
Markets

HCW starts Celyad at buy; PT $45

H.C. Wainwright initiated coverage of Celyad (NASDAQ:CYAD) with a “buy” rating and $45 price target, citing the outlook of the company’s pipeline that includes lead candidate, CYAD-01. The stock closed at $30.99...

July 2, 2018
Neuronetics Logo
Markets

Neuronetics prices IPO at $17 a share

Neuronetics (NASDAQ:STIM) priced its initial public offering of 5.5 million shares common shares at $17 each. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares at the...

June 29, 2018
AquaBounty Logo
Markets

HCW starts AquaBounty at buy; PT $3.75

H.C. Wainwright launched coverage of AquaBounty Technologies (NASDAQ:AQB) with a “buy” rating and a “conservative” $3.75 price target. The stock closed at $2.99 on June 27. AquaBounty is focused on enhancing...

June 28, 2018
TransEnterix
Markets

BTIG cuts TransEnterix to neutral on rapid stock rise

BTIG downgraded TransEnterix (NASDAQ:TRXC) to “neutral” from “buy,” citing a tripling in the stock price, which has exceeded its price target of $3.50. The stock closed at $5.84 on June 27. “We continue to like the...

June 28, 2018